In 2018, investors made a fortune with pot stocks. Every company was doubling, tripling, or even quadrupling in price. It was like shooting fish in a barrel with all the water drained out. The 2019 bear market changed everything. The hype cycle ended, and many competitors never recovered. The COVID-19 crisis of 2020 continued the pain. Most pot stocks still…
Read More
It was popular for a while to refer to the cannabis space as another dot-com bubble. There were definitely similarities: a new industry full of potential was getting investors exciting, driving up share prices until the bubble burst. Post-legalization, many of the great green hopes touted by early cannabis bulls were up in smoke, to use a tired idiom. But…
Read More
The Canadian cannabis market shifted into a new gear with the launch of Cannabis 2.0 products in late 2019. Cannabis 2.0 products include edibles, extracts, and vaporizers. This segment of the cannabis market carries with it much higher profit margins than dried flower products do. Companies and investors are thus cautiously optimistic about a second green rush occurring. These three…
Read More
Pot stocks are a proven way to make money. In 2018, many skyrocketed in value by more than 1,000%. To be sure, cannabis is also a proven way to lose money. The marijuana bear market of 2019, for example, saw the industry lose half of its value in a matter of months. Long term, however, the biggest gains are still…
Read More
Molson Coors Canada Inc. (TSX:TPX.B)(NYSE:TAP) is one of the most popular brands in Canada. Its market cap exceeds $10 billion, giving it plenty of liquidity to pursue long-term growth opportunities. If you look closely, it’s clear that Molson is about to send shares of one pot stock soaring. It’s important to note that Molson hasn’t entered the marijuana industry directly.…
Read More
Pot stock investors: watch this space. Cannabis stocks could get a second wind, as researchers investigate whether cannabis could be an effective treatment for COVID-19. Indeed, as the coronavirus market searches for solutions, cannabis could take centre stage. But is Aphria (TSX:APHA)(NASDAQ:APHA) the best stock to buy for this eventuality? Let’s discuss this compelling new thesis. Researchers are getting cannabinoid…
Read More
Altria Group (NYSE:MO) is one of the largest tobacco producers in the world. Its size is truly remarkable. Last quarter, despite the onset of the COVID-19 pandemic, the company generated more than $5 billion in sales. It also produced a quarterly profit of nearly $2 billion, up 38% year over year. Those profits help service an 8.6% dividend. If you…
Read More
Pot stocks have been a roller coaster ride this year. At the start of 2020, cannabis companies were hit hard by the coronavirus correction. These pressures came after the terrible marijuana bear market of 2019, which saw industry valuations cut in half. Recent weeks, however, have brought much-needed relief. Indeed, some companies are seeing their share prices soar. One of…
Read More
Pot stocks had a tough 2019. The start of 2020 was no easier. Since their all-time highs, many marijuana companies have seen their shares reduced by 70% or more. Recent weeks have been a different story. One producer in particular has seen its stock move from $0.60 to $1.50 in just 20 days. There’s reason to believe this momentum will…
Read More
In 2018, pot stocks were going gangbusters. Several new startups attained billion-dollar valuations. The party ended in 2019, when the majority of the industry fell by more than 50%. Some smaller competitors lost 90% of their value. What does the future hold for 2020? So far, the results have been mixed. The worst of the 2019 bear market is now…
Read More